Our Research Publications
Updated August 2025
Pagination
- Previous page
- Page 32
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Concentré de recherche: Traitement périopératoire des patients atteints de thrombocytopénie immunitaire : comparaison de l’eltrombopag et des immunoglobulines intraveineuses | Arnold DM | 2021 | Blood.ca website | Health care providers | Clinical research | |
High sub-zero organ preservation: A paradigm of nature-inspired strategies | William N, Acker JP | 2021 | Cryobiology | View High sub-zero organ preservation: A paradigm of nature-inspired strategies | Researchers | Basic research |
Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Paredes C, Chi SI, Flint A, Weedmark K, McDonald C, Bearne J, Ramirez-Arcos S, Pagotto F, Baltrus DA | 2021 | Microbiol Resour Announc | View Complete Genome Sequence of Staphylococcus aureus PS/BAC/169/17/W, Isolated from a Contaminated Platelet Concentrate in England | Researchers | Benchmarking and standard setting |
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O’Brien SF, the Surveillance Risk Assessment Policy tVS-gotI, Transfusion Transmitted Infectious Diseases Working Party | 2021 | Vox Sang | View An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Blood operators | Benchmarking and standard setting |
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Huang CT, Hsu SY, Wang CH, Tseng WJ, Yang CY, Ng CJ, Warkentin TE, Cheng MH | 2021 | Thromb Res | View Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL | 2021 | Transfusion | View The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Blood operators | Benchmarking and standard setting |
A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies | Yao Z, Drecun L, Aboualizadeh F, Kim SJ, Li Z, Wood H, Valcourt EJ, Manguiat K, Plenderleith S, Yip L, Li X, Zhong Z, Yue FY, Closas T, Snider J, Tomic J, Drews SJ, Drebot MA, McGeer A, Ostrowski M, Mubareka S, Rini JM, Owen S, Stagljar I | 2021 | Nat Commun | View A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies | Researchers | New or improved product or process |
Releasates of riboflavin/UV-treated platelets: Microvesicles suppress cytokine-mediated endothelial cell migration/proliferation | Schubert P, Culibrk L, Culibrk B, Conway EM, Goodrich RP, Devine DV | 2021 | Transfusion | View Releasates of riboflavin/UV-treated platelets: Microvesicles suppress cytokine-mediated endothelial cell migration/proliferation | Researchers | Basic research |
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Writing Committee for the REMAP-CAP Investigators | 2021 | JAMA | View Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Health care providers | Clinical research |
Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time | Stonebraker JS, O'Mahony B, Noone D, Iorio A | 2021 | Haemophilia | View Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time | Researchers | Benchmarking and standard setting |
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Prokopchuk-Gauk O, Petraszko T, Nahirniak S, Doncaster C, Levy I | 2021 | Transfusion | View Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Regulators | Benchmarking and standard setting |
Concentré de recherche: Précision et efficacité accrues dans la gestion des réserves de sang | Li N | 2021 | Blood.ca website | View Concentré de recherche: Précision et efficacité accrues dans la gestion des réserves de sang | Health care providers | New or improved product or process |
Examining prescribing practices with respect to oral iron supplementation for post-partum anemia: a retrospective review | Iancu AM, Buckstein J, Melamed N, Lin Y | 2021 | J Matern Fetal Neonatal Med | View Examining prescribing practices with respect to oral iron supplementation for post-partum anemia: a retrospective review | Health care providers | Clinical research |
Evaluation of the sexual health in people living with hemophilia | Germini F, Chai-Adisaksopha C, Pete D, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker JS, Thabane L, Crowther MA, Skinner MW, Iorio A | 2021 | Haemophilia | View Evaluation of the sexual health in people living with hemophilia | Researchers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Chapter 4: Clinical transfusion procedures | Clarke G, Al-Riyami AZ, Roxby D | 2021 | Educational Modules on Clinical Use of Blood | View Chapter 4: Clinical transfusion procedures | Health care providers | Benchmarking and standard setting |
ResearchUnit: Platelet Transfusion in Children with Cancer | Barty R | 2021 | Blood.ca website | View ResearchUnit: Platelet Transfusion in Children with Cancer | Health care providers | Benchmarking and standard setting |
Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy | Balitsky AK, Liu Y, Van der Meer PF, Heddle NM, Arnold DM | 2021 | Transfusion | View Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy | Researchers | Clinical research |
Irradiated, Washed and CMV Seronegative Blood Components | Prokopchuk-Gauk O, Solh Z | 2021 | Clinical Guide to Transfusion | View Irradiated, Washed and CMV Seronegative Blood Components | Health care providers | Benchmarking and standard setting |
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Saeed S, Drews SJ, Pambrun C, Yi Q-L, Osmond L, O'Brien SF | 2021 | Transfusion | View SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Researchers | Clinical research |
Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Verma AA, Pai M, Saha S, Bean S, Fralick M, Gibson JL, Greenberg RA, Kwan JL, Lapointe-Shaw L, Tang T, Morris AM, Razak F | 2021 | CMAJ | View Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Health care providers | Benchmarking and standard setting |
Surveillance report 2020 | O'Brien S | 2021 | Blood.ca website | View Surveillance report 2020 | Health care providers | Benchmarking and standard setting |
Répercussions de la COVID-19 sur le don de sang au Canada | Khandelwal A | 2021 | Blood.ca website | View Répercussions de la COVID-19 sur le don de sang au Canada | Health care providers | Benchmarking and standard setting |
Syndrome respiratoire aigu post-transfusionnel (TRALI) | Gupta A, Yan M | 2021 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Health care providers | Benchmarking and standard setting |
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Bourguignon A, Arnold DM, Warkentin TE, Smith JW, Pannu T, Shrum JM, Al Maqrashi ZAA, Shroff A, Lessard M-C, Blais N, Kelton JG, Nazy I | 2021 | N Engl J Med | View Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Clinical research |
ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Abe T | 2021 | Blood.ca website | View ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Health care providers | Clinical research |
Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study | Alabdullatif M, Osman IE, Alrasheed M, Ramirez-Arcos S, Alyousef M, Althawadi S, Alhumiadan H | 2021 | Transfusion | View Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study | Researchers | New or improved product or process |
A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors | Drews SJ, Devine DV, McManus J, Mendoza E, Manguiat K, Wood H, Girardin R, Dupuis A, McDonough K, Drebot M | 2021 | Transfusion | View A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors | Researchers | Basic research |
Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference | Spinella PC, El Kassar N, Cap AP, Kindzelski AL, Almond CS, Barkun A, Gernsheimer TB, Goldstein JN, Holcomb JB, Iorio A, Jensen DM, Key NS, Levy JH, Mayer SA, Moore EE, Stanworth SJ, Lewis RJ, Steiner ME | 2021 | J Trauma Acute Care Surg | View Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference | Researchers | Benchmarking and standard setting |
ResearchUnit: Treating bleeding during cardiac surgery: Is prothrombin complex concentrate a substitute for plasma? | Kron A | 2021 | Blood.ca website | View ResearchUnit: Treating bleeding during cardiac surgery: Is prothrombin complex concentrate a substitute for plasma? | Health care providers | Clinical research |
The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP | 2021 | Cytotherapy | View The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Blood operators | New or improved product or process |
Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider | El-Khoury H, Saifi O, Haddad S, Chahrour M, Ghanem KM, Mubarak Y, Tamim H, Makki M, Zakka C, Chan AK, Mahfouz R, Tarek N, El-Solh H, Abboud MR, Saab R, Muwakkit SA | 2021 | Pediatr Blood Cancer | View Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider | Health care providers | Clinical research |
Discrete-Event Simulation to Model the Thrombolysis Process for Acute Ischemic Stroke Patients at Urban and Rural Hospitals | Bulmer T, Volders D, Blake J, Kamal N | 2021 | Front Neurol | View Discrete-Event Simulation to Model the Thrombolysis Process for Acute Ischemic Stroke Patients at Urban and Rural Hospitals | Researchers | New or improved product or process |
Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology | Al-Samkari H, Cronin A, Arnold DM, Rodeghiero F, Grace RF | 2021 | J Thromb Haemost | View Extensive variability in platelet, bleeding, and QOL outcome measures in adult and pediatric ITP: Communication from the ISTH SSC subcommittee on platelet immunology | Health care providers | Benchmarking and standard setting |
A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Kron AT, Collins A, Cserti-Gazdewich C, Pendergrast J, Webert K, Lieberman L, Zeller MP, Harding SR, Nahirniak S, Prokopchuk-Gauk O, Lin Y, Mendez B, Armali C, Lee C, Watson D, Arnott D, Xun F, Blain H, Panchuk H, Hughes H, Chorneyko K, Angers M, Pilutti N, Lett R, Dowsley S, Ruijs T, Cupido T, Kichinko T, Thompson T, Afshar-Ghotli Z, Callum J, University of Toronto Quality in Utilization, Education and Safety in Transfusion (QUEST) Research Program | 2021 | Transfusion | View A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study | Health care providers | Clinical research |
Tantalum-containing meso-porous glass fibres for hemostatic applications | Nagrath M, Rahimnejad Yazdi A, Rafferty A, Daly D, Rahman SU, Gallant RC, Ni H, Arany PR, Towler MR | 2021 | Mater Today Commun | View Tantalum-containing meso-porous glass fibres for hemostatic applications | Researchers | Basic research |
Genome Sequence of Staphylococcus aureus Strain CBS2016-05, Isolated from Contaminated Platelet Concentrates in Canada | Yousuf B, Flint A, Weedmark K, Pagotto F, Ramirez-Arcos S, Hotopp JCD | 2021 | Microbiol Resour Announc | View Genome Sequence of Staphylococcus aureus Strain CBS2016-05, Isolated from Contaminated Platelet Concentrates in Canada | Researchers | Benchmarking and standard setting |
Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Ma Y, Hadjesfandiari N, Doschak M, Devine D, Tonelli M, Unsworth L | 2021 | Langmuir | View Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Researchers | Basic research |
A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Jiang D, Lim W, Crowther M, Garcia D | 2021 | Blood Adv | View A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Researchers | Clinical research |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial | Bégin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chassé M, Devine DV, Robitalle N, Bazin R, Shehata N, Finzi A, McGeer A, Scales DC, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Sachais BS, Loftsgard KC, Jamula E, Carruthers J, Duncan J, Lucier K, Li N, Liu Y, Armali C, Kron A, Modi D, Auclair M-C, Cerro S, Avram M, Arnold DM | 2021 | Trials | View Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial | Researchers | Clinical research |
Filariasis and transfusion-associated risk: a literature review | Drews SJ, Spencer BR, Wendel S, Bloch EM, International Society of Blood Transfusion TTID Working Party Parasite Subgroup | 2021 | Vox Sang | View Filariasis and transfusion-associated risk: a literature review | Health care providers | Clinical research |
Stepping Stones or Second Class Donors?: a qualitative analysis of gay, bisexual, and queer men's perspectives on plasma donation policy in Canada | Grace D, Gaspar M, Klassen B, Lessard D, Anand P, Brennan DJ, Lachowsky N, Adam BD, Cox J, Lambert G, Jollimore J, Hart TA | 2021 | BMC Public Health | View Stepping Stones or Second Class Donors?: a qualitative analysis of gay, bisexual, and queer men's perspectives on plasma donation policy in Canada | Blood operators | MSM research |
Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Goldman M, Townsend M, Magnussen K, Lozano M, Nissen-Meyer LS, Lee CK, Leung JN, Takanashi M, McKay J, Kvist M, Robitaille N, Deschênes J, Di Angelantonio E, McMahon A, Roberts D, Maghsudlu M, Castrén J, Tiberghien P, Woimant G, Morel P, Kamel H, Bravo M, Shinhar E, Gendelman V, Raz H, Wendel S, Fachini R, Quee F, van den Hurk K, Wiersum J, Grima K, Speedy J, Bruun M, Dunbar N | 2021 | Vox Sang | View Vox Sanguinis International Forum on Mitigation Strategies to Prevent Faint and Pre-faint Adverse Reactions in Whole Blood Donors: Summary | Health care providers | Benchmarking and standard setting |
Effect of cryopreservation on a rare McLeod donor red blood cell concentrate | Turner TR, Clarke G, Denomme GA, Skeate R, Acker JP | 2021 | Immunohematology | View Effect of cryopreservation on a rare McLeod donor red blood cell concentrate | Researchers | Basic research |
A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study | Savage RD, Bell CA, Righolt CH, Wilkinson K, Schwartz KL, Chen C, Bolotin S, Deeks SL, Drews SJ, Jamieson FB, Johnson C, Kwong JC, Mahmud SM, Russell ML, Simmonds KA, Svenson LW, Crowcroft NS | 2021 | Vaccine | View A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study | Researchers | Clinical research |
ResearchUnit: Convalescent plasma is an ineffective treatment for patients with COVID-19 | Modi D | 2021 | Blood.ca website | View ResearchUnit: Convalescent plasma is an ineffective treatment for patients with COVID-19 | Health care providers | Clinical research |
GPIb? is the driving force of hepatic thrombopoietin generation | Karakas D, Xu M, Ni H | 2021 | Res Pract Thromb Haem | View GPIb? is the driving force of hepatic thrombopoietin generation | Researchers | Basic research |
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia | Greinacher A, Selleng K, Palankar R, Wesche J, Handtke S, Wolff M, Aurich K, Lalk M, Methling K, Völker U, Hentschker C, Michalik S, Steil L, Reder A, Schönborn L, Beer M, Franzke K, Büttner A, Fehse B, Stavrou EX, Rangaswamy C, Mailer RK, Englert H, Frye M, Thiele T, Kochanek S, Krutzke L, Siegerist F, Endlich N, Warkentin TE, Renné T | 2021 | Blood | View Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia | Researchers | Basic research |
The Virulence of S. marcescens Strains Isolated From Contaminated Blood Products Is Divergent in the C. elegans Infection Model | Diamandas A, Razon MR, Ramirez-Arcos S, Brassinga AKC | 2021 | Front Genet | View The Virulence of S. marcescens Strains Isolated From Contaminated Blood Products Is Divergent in the C. elegans Infection Model | Researchers | Basic research |
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life | Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, Ghanima W, Arnold DM, Tomiyama Y, Santoro C, Michel M, Laborde S, Lovrencic B, Hou M, Bailey T, Taylor-Stokes G, Haenig J, Bussel JB | 2021 | Am J Hematol | View Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life | Researchers | Clinical research |